Adenosine triphosphate (ATP)
ADVERTISEMENT
- Molecular formula
- C10H16N5O13P3
- CAS Number
- 56-65-5
- IUPAC Name
- [[[[5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid
- Molecular Weight
- 507.18g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.5000g/cm3
- Synonyms
- phosphoaminophosphonic acid-adenylate ester
Identification
Interesting facts
Interesting Facts about 5-(6-Aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid
This complex compound exemplifies the intricate world of nucleotide analogs, which play crucial roles in biological systems and therapeutic applications. Below are some fascinating insights about this compound:
- Nucleotide Mimicry: The structure of this compound resembles natural nucleotides, allowing it to potentially interfere with nucleic acid synthesis. Researchers often study such compounds to understand their effects on cellular processes.
- Potential Antiviral Activity: Compounds that feature similar structures to nucleotides, like this one, are often explored for their ability to act as antivirals by inhibiting viral replication.
- Phosphonic Acid Importance: The presence of phosphonic acid groups in its structure is significant. Phosphonates have been widely used in agriculture as herbicides and fertilizers, and in medicine as antiviral agents.
- Multiple Hydroxy Groups: This compound contains multiple hydroxy groups, which can lead to interesting interactions with enzymes and proteins, affecting biochemical pathways and metabolic processes.
- Research Applications: Given its elaborate structure, it serves as a fascinating subject for chemists and biochemists, prompting research into drug design, enzyme inhibition, and cellular signaling pathways.
In conclusion, this compound is not just a chemical entity; it holds promise for advancements in medicinal chemistry and biotechnology, allowing scientists to explore novel therapeutic avenues.